117 Perspectives on cancer screening participation References 1. European Commission, Directorate-General for Research and Innovation, Group of Chief Scientific Advisors. Cancer screening in the European Union, 2022. 2. van Ballegooijen M, van den Akker-van Marle E, Patnick J, Lynge E, Arbyn M, Anttila A, et al. Overview of important cervical cancer screening process values in European Union (EU) countries, and tentative predictions of the corresponding effectiveness and costeffectiveness. Eur J Cancer. 2000;36(17):2177-88. 3. van Ballegooijen M, Hermens R. Cervical cancer screening in The Netherlands. European Journal of Cancer. 2000;36(17):2244-6. 4. European Colorectal Cancer Screening Guidelines Working Group. von Karsa L, Patnick J, Segnan N, Atkin W, Halloran S, et al. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication. Endoscopy. 2013;45(1):51-9. 5. Verbeek ALM, Broeders MJM. Evaluation of The Netherlands breast cancer screening programme. Annals of Oncology. 2003;14(8):1203-5. 6. Rijksinstituut voor Volksgezondheid en Milieu. Population screening programmes 2021 https://www.rivm.nl/node/99391. Accessed June 2021. 7. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Baarmoederhalskanker 2020. https://www.rivm.nl/bevolkingsonderzoekbaarmoederhalskanker/professionals/monitoring-en-evaluatie. Accessed June 2021. 8. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Borstkanker 2020. https://www.rivm.nl/bevolkingsonderzoek-borstkanker/professionals/monitoringen-evaluatie. Accessed June 2021. 9. Rijksinstituut voor Volksgezondheid en Milieu. Monitor Bevolkingsonderzoek Darmkanker 2020. https://www.rivm.nl/bevolkingsonderzoek-darmkanker/professionals/monitoringen-evaluatie. Accessed June 2021. 10. Young B, Robb KA. Understanding patient factors to increase uptake of cancer screening: a review. Future Oncology. 2021;17(28):3757-75. 11. Lynge E, Törnberg S, von Karsa L, Segnan N, van Delden JJ. Determinants of successful implementation of population-based cancer screening programmes. European journal of cancer. 2012;48(5):743-8. 12. World Health Organization. Cancer control: Early detection. WHO guide for effective programmes, 2007. 13. World Health Organization. National cancer control programmes: policies and managerial guidelines: World Health Organization, 2002. 14. World Health Organization. Guide to cancer early diagnosis, 2017. 15. Bevolingsonderzoek Nederland. Jaarbericht 2020. https://www. jaarberichtbevolkingsonderzoeknederland2020.nl. Accessed June 2021. 16. Bongaerts THG, Büchner FL, Middelkoop BJ, Guicherit OR, Numans ME. Determinants of (non-) attendance at the Dutch cancer screening programmes: A systematic review. Journal of medical screening. 2020;27(3):121-9. 17. Myers L, Goodwin B, Ralph N, March S. A health action process approach for developing invitee endorsed interventions to increase mail‐out bowel cancer screening. Applied Psychology: Health and Well‐Being. 2022. 18. Wearn A, Shepherd L. Determinants of routine cervical screening participation in underserved women: a qualitative systematic review. Psychology & Health. 2022:1-26. 4
RkJQdWJsaXNoZXIy MTk4NDMw